BioAge Labs shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $9 to $62.
Original source ↗  |  February 18, 2026 at 10:16 UTC  |  Finnhub - BIOA

No analysis available.

Trade Ideas
Ticker Direction Speaker Thesis Time
NONE Finnhub News